Company Overview
STOKE THERAPEUTICS, INC.
STOKRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
184M
2025 FY
Net Income
-7M
2025 FY
Shares Outstanding
59M
2025 FY
EPS
-0.12USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1623526
Exchange
Nasdaq
Location
US